SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001553350-17-001035
Filing Date
2017-09-15
Accepted
2017-09-15 07:01:19
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDED QUARTERLY REPORT htbx_10q.htm 10-Q/A 465220
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex31z1.htm EX-31.1 10955
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex31z2.htm EX-31.2 10944
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER htbx_ex32z1.htm EX-32.1 4691
5 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER htbx_ex32z2.htm EX-32.2 4563
  Complete submission text file 0001553350-17-001035.txt   2762189

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE htbx-20170630.xml EX-101.INS 420600
7 XBRL SCHEMA FILE htbx-20170630.xsd EX-101.SCH 29397
8 XBRL CALCULATION FILE htbx-20170630_cal.xml EX-101.CAL 60139
9 XBRL DEFINITION FILE htbx-20170630_def.xml EX-101.DEF 90652
10 XBRL LABEL FILE htbx-20170630_lab.xml EX-101.LAB 273128
11 XBRL PRESENTATION FILE htbx-20170630_pre.xml EX-101.PRE 200673
Mailing Address 801 CAPITOLA DRIVE DURHAM NC 27713
Business Address 801 CAPITOLA DRIVE DURHAM NC 27713 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-35994 | Film No.: 171086854
SIC: 2834 Pharmaceutical Preparations